ESR1 and breast carcinoma: Three different cancer cell lines representing different breast cancer subtypes, estrogen receptor‐positive MCF7 and T‐47D and estrogen receptor‐negative MDA‐MB‐231, were used to repopulate the PDSs, and gene expression analyses were used to determine the cellular phenotypes of cells enriched by the drug treatments.